A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients

被引：1

作者：

Burkhardt, Olaf ^{[2
]}

Kielstein, Jan T. ^{[1
]}

机构：

[1] Hannover Med Sch, Dept Hypertens & Nephrol, D-30625 Hannover, Germany

[2] Hannover Med Sch, Dept Pulm Med, D-30625 Hannover, Germany

来源：

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2010年 / 8卷 / 01期

关键词：

daptomycin; dialysis; end-stage renal disease; infection; pharmacokinetics; STAGE RENAL-DISEASE; PHARMACOKINETICS; MORTALITY; KIDNEY;

D O I：

10.1586/ERI.09.121

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Approximately 2.3 million patients worldwide are undergoing chronic renal replacement therapy. In that population, acute infections substantially contribute to the excessive morbidity and mortality. The risk for invasive methicillin-resistant Staphylococcus aureus infections in this population is approximately 100-fold higher than in the general population, therefore dialysis patients currently account for up to approximately 15% of all invasive methicillin-resistant Staphylococcus aureus infections. A simplified three-times weekly dosing regimen for hemodialysis patients now allows for practical, hassle-free and effective treatment with claptomycin, which is licensed for the treatment of complicated skin and soft tissue infections, including resistant strains of Staphylococcus aureus and life-threatening Gram-positive infections, vancomycin-resistant enterococcal infections and right-sided endocarditis.

引用

页码：11 / 14

页数：4

共 42 条

[31] Safety and Efficacy of Vadadustat Once Daily and Three Times Weekly in Patients With Dialysis-Dependent CKD With Anemia [J].

Kooienga, Laura ;

Burke, Steven ;

Kathresal, Amarnath ;

Luo, Wenli ;

Yang, Zhihui ;

Zhang, Zhiqun ;

Zwiech, Rafal ;

Hernandez, German T. .

KIDNEY360, 2024, 5 (11) :1652-1661

[32] Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease [J].

Masaru Samura ;

Keisuke Takada ;

Risako Yamamoto ;

Hayato Ito ;

Fumio Nagumo ;

Masaki Uchida ;

Takenori Kurata ;

Sakura Koshioka ;

Yuki Enoki ;

Kazuaki Taguchi ;

Ryuji Higashita ;

Norifumi Kunika ;

Koji Tanikawa ;

Kazuaki Matsumoto .

Pharmaceutical Research, 2021, 38 :1041-1055

[33] Population Pharmacokinetic Analysis and Dosing Optimization Based on Unbound Daptomycin Concentration and Cystatin C in Nonobese Elderly Patients with Hypoalbuminemia and Chronic Kidney Disease [J].

Samura, Masaru ;

Takada, Keisuke ;

Yamamoto, Risako ;

Ito, Hayato ;

Nagumo, Fumio ;

Uchida, Masaki ;

Kurata, Takenori ;

Koshioka, Sakura ;

Enoki, Yuki ;

Taguchi, Kazuaki ;

Higashita, Ryuji ;

Kunika, Norifumi ;

Tanikawa, Koji ;

Matsumoto, Kazuaki .

PHARMACEUTICAL RESEARCH, 2021, 38 (06) :1041-1055

[34] Evaluation of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Among Patients on twice weekly Hemodialysis in Khartoum Teaching Hospital, Sudan [J].

Dosogi, Waleed Abd Alrazig ;

Abdelwahab, Hisham Hassan ;

Elsheikh, Maha Ali Hummeida ;

Mustafa, Alam Eldin Musa .

BAHRAIN MEDICAL BULLETIN, 2022, 44 (02) :912-917

[35] Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis [J].

Hainer, JW ;

Sherrard, DJ ;

Swan, SK ;

Barrett, JS ;

Assaid, CA ;

Fossler, MJ ;

Cox, DS ;

Williams, RM ;

Pittenger, AL ;

Stephenson, CA ;

Hua, TA .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (03) :531-538

[36] A Simplified Approach to Extravascular Lung Water Assessment Using Point-of-Care Ultrasound in Patients with End-Stage Chronic Renal Failure Undergoing Hemodialysis [J].

Beaubien-Souligny, William ;

Rheaume, Maxime ;

Blondin, Marie-Christine ;

El-Barnachawy, Sherine ;

Fortier, Annik ;

Ethier, Jean ;

Legault, Louis ;

Denault, Andre Y. .

BLOOD PURIFICATION, 2018, 45 (1-3) :79-87

[37] Daily versus three-times-weekly azithromycin in Chinese patients with non-cystic fibrosis bronchiectasis: protocol for a prospective, open-label and randomised controlled trial [J].

Mao, Yanxiong ;

Chen, Lan ;

He, Ting ;

Li, Jing ;

Zou, Aiping ;

Li, Feng ;

Chen, Fei ;

Fan, Bo ;

Ni, Weihao ;

Xiao, Wei ;

You, Huimin ;

Fu, Wenjiang .

BMJ OPEN, 2022, 12 (07)

[38] Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patients [J].

Stephens, J. Mark ;

Emerson, Larry C. ;

Spry, Leslie A. ;

Caloyeras, John P. ;

Anderson, Ernest R. ;

Reitan, John F. ;

Ashfaq, Akhtar .

CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (02) :313-320

[39] How Can Erythropoeitin-Stimulating Agent Use be Reduced in Chronic Dialysis Patients?: The Use of Iron Supplementation to Reduce ESA Dosing in Hemodialysis [J].

Shirazian, Shayan ;

Grant, Candace ;

Miller, Ilene ;

Fishbane, Steven .

SEMINARS IN DIALYSIS, 2013, 26 (05) :534-536

[40] Impact of Interdialytic Intervals on Sudden Cardiac Death in Chronic Kidney Disease Stage 5D Patients on a Twice-Weekly Hemodialysis Schedule [J].

Kumar, Prasanna ;

Savant, Kshama ;

Balakrishnan, Athira ;

Nair, Sreedharan ;

Attur, Ravindra Prabhu .

KIDNEY & BLOOD PRESSURE RESEARCH, 2025, 50 (01) :420-428

← 1 2 3 4 5 →